Anzeige
Mehr »
Login
Samstag, 22.02.2025 Börsentäglich über 12.000 News von 688 internationalen Medien
851 % Rendite in 30 Tagen: Die KI-Aktie, die seit der Integration von Deepseek R1 Wellen schlägt!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A401UY | ISIN: US36151G6008 | Ticker-Symbol: 12Q0
Lang & Schwarz
22.02.25
09:00 Uhr
1,475 Euro
0,000
0,00 %
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
INTELLIGENT BIO SOLUTIONS INC Chart 1 Jahr
5-Tage-Chart
INTELLIGENT BIO SOLUTIONS INC 5-Tage-Chart
RealtimeGeldBriefZeit
1,4601,49009:00

Aktuelle News zur INTELLIGENT BIO SOLUTIONS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
FrINTELLIGENT BIO SOLUTIONS INC. - 8-K, Current Report-
FrIntelligent Bio Solutions, Inc.: Intelligent Bio Solutions Inc. Announces Closing of $3.0 Million Public Offering of Common Stock and Full Exercise of the Underwriter's Option to Purchase Additional Shares of Common Stock2
DoIntelligent Bio Solutions Inc. Announces $2.6 Mln Common Stock Offering Pricing3
DoIntelligent Bio Solutions announces pricing of $2.6 million public offering; shares fall2
DoIntelligent Bio Solutions, Inc.: Intelligent Bio Solutions Inc. Announces Pricing of $2.6 Million Public Offering of Common Stock7
MiIntelligent Bio Solutions, Inc.: Intelligent Bio Solutions Inc. Announces Proposed Public Offering of Common Stock4
13.02.INTELLIGENT BIO SOLUTIONS INC. - 8-K, Current Report1
13.02.INTELLIGENT BIO SOLUTIONS INC. - 10-K/A, Annual Report2
INTELLIGENT BIO SOLUTIONS Aktie jetzt für 0€ handeln
13.02.Intelligent Bio Solutions GAAP EPS of -$0.50, revenue of $0.61M3
13.02.INTELLIGENT BIO SOLUTIONS INC. - 10-Q, Quarterly Report2
10.02.Intelligent Bio Solutions, Inc.: Intelligent Bio Solutions Releases Shareholder Letter Detailing 2024 Growth and 2025 U.S. Expansion Strategy187NEW YORK, Feb. 10, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing...
► Artikel lesen
07.02.Intelligent Bio Solutions expands with UK partnership8
07.02.Intelligent Bio Solutions, Inc.: Intelligent Bio Solutions Expands with UK Partnership, Driving Global Growth Ahead of Planned U.S. Launch2
06.02.INTELLIGENT BIO SOLUTIONS INC. - 8-K, Current Report-
06.02.Intelligent Bio Solutions reports preliminary Q2 revenue $0.61M3
06.02.Intelligent Bio Solutions, Inc.: Intelligent Bio Solutions expects to achieve 32.6% Gross Profit Expansion and Increased Profitability on Higher-Margin Sales100Gross profit expected to surge by 32.6% Unaudited revenue of $0.61 million for fiscal Q2 and $1.48 million for the six months ended December 31, 2024 Higher-margin cartridge sales driving profitability...
► Artikel lesen
31.01.INBS drug screening system to support multiple languages6
31.01.Intelligent Bio Solutions, Inc.: Intelligent Bio Solutions Expands Global Reach with Multilingual Drug Screening System Upgrade3
29.01.Intelligent Bio Solutions, Inc.: Intelligent Bio Solutions Adds Quantum TM to 400+ Account Portfolio Utilizing Breakthrough Fingerprint Drug Testing4
29.01.EXCLUSIVE: Intelligent Bio Solutions Partners With UK-Based Quantum TM For Fingerprint Drug Testing At 10 Sites4
Seite:  Weiter >>
78 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1